ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2022ACC: 0001209191-22-022532
Officer· Interim CFO
Since Jun 2021
-773.00
Net shares
Net seller
$502.45
Total sold
0
Open market trades
0B · 0S
1
Total transactions
773.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−773.00
Price / share
$0.65
Trade value
$502.45
% of position
0.5%
3/31/2022
162.33K→161.56K
Total
Net shares
−773.00
Net value
-$502.45
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2022 | F · Tax Withholding | −773.00 | $0.65 | $502.45 | 0.5% | 162.33K | 161.56K |
| Total | −773.00 | -$502.45 | ||||||
Derivative Transactions0
No derivative transactions reported